logo

For the Inventor, By the Inventor

Dallas, TX, United States of America

Edward R Biehl

This inventor holds 7 USPTO granted patents and 3 published patent applications. Top assignees: Southern Methodist University, Chk Group, Inc., Johns Hopkins University. Active years: 2011-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward R Biehl. Retrieved from https://idiyas.com/inventor/edward-r-biehl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 14.3

Average Co-Inventor Count = 3.2

ph-index = 1


Company Filing History:

goldMedal6 out of 119 
 
Southern Methodist University
 patents
silverMedal1 out of 8 
 
Chk Group, Inc.
 patents
bronzeMedal1 out of 3,798 
 
Johns Hopkins University
 patents
4. 1 out of 5,633 
 
The University of Texas System
 patents
where one patent can have more than one assignee

Years Active: 2011-2018

Loading Chart...
7 patents (USPTO):Explore Patents
1. 10093681 - Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors (2018-10-09),
2. 9567305 - Quinoxaline compounds and derivatives (2017-02-14),
3. 9493452 - Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors (2016-11-15),
4. 9309208 - Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors (2016-04-12),
5. 8680094 - 1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions (2014-03-25),
6. 8669363 - Quinoxaline compounds and derivatives (2014-03-11),
7. 8084662 - Method for degrading chemical warfare agents using Mn(VII) oxide with-and-without solid support (2011-12-27),

Title: Innovator Spotlight: Edward R Biehl

Introduction:

Edward R Biehl, a prominent inventor based in Dallas, TX, has made significant contributions to the field of pharmaceuticals with his innovative patents. With a total of 7 patents to his name, Biehl is recognized for his groundbreaking work in developing compounds and derivatives for therapeutic purposes.

Latest Patents:

Among his latest patents, Edward R Biehl has introduced compounds and derivatives of 2H-pyrido(3,2-b)(1,4)oxazin-3(4H)-ones as raf kinase and LRRK2 inhibitors. Additionally, he has brought forth quinoxaline compounds and derivatives, showcasing his expertise in pharmacological advancements. These inventions offer new possibilities for the treatment of various medical conditions.

Career Highlights:

Edward R Biehl has gathered invaluable experience working with esteemed institutions such as Southern Methodist University and The Johns Hopkins University. His dedication to research and development has led to transformative discoveries in the pharmaceutical industry, earning him recognition among his peers.

Collaborations:

Throughout his career, Edward R Biehl has collaborated with skilled professionals in the field, including notable coworkers like Haribabu Ankati and Sukanta Kamila. Together, they have synergized their expertise to drive innovation and produce remarkable results in drug development.

Conclusion:

In conclusion, Edward R Biehl stands out as a prolific inventor whose patents exemplify his commitment to advancing pharmaceutical sciences. His pioneering work continues to inspire new avenues for medical research and underscores the importance of innovative thinking in the field of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…